IPSIndian Journal of Pharmacology
Home  IPS  Feedback Subscribe Top cited articles Reader Login
Users Online : 1051 
Small font sizeDefault font sizeIncrease font size
Navigate Here
     My Preferences 
     Manuscript submission

 


Export selected to
Endnote
Reference Manager
Procite
Medlars Format
RefWorks Format
BibTex Format
  Access statistics : Table of Contents
   1980| January-March  | Volume 12 | Issue 1  
 
 
  Archives   Previous Issue   Next Issue   Most popular articles   Most cited articles
 
Hide all abstracts  Show selected abstracts  Export selected to
  Viewed PDF Cited
RESEARCH PAPER
A clinical trial with mebendazole in taeniasis saginata and Hymenolepis nana
KC Singhal, RA Khan, PN Saxena
January-March 1980, 12(1):19-22
. Mebendazole, a broad spectrum anthehnintic was evaluated in 32 patients parasitized with tape worm infestations. Eighteen patients were identified as having Hymenolepis nana and 14 as having Taenia saginata. Seventeen patients in addition, were found to have concomitant nematode infection. Patients were treated with one of the five dosage schedules (100 mg b.d. x 3 days, 100 mg q.i.d. x 3 days, 300 mg b.d. x 1 day, 300 mg b.d. x 3 days and 500 mg b.d. x 1 day). Treatment resulted in the passage of long chains of proglottids of T. saginata and whole worms of H. nana. Assessment of results was made at 15 day intervals for 3 months. The most effective dosage schedule was 300 mg b.d. for 3 days which resulted in curing all the six patients suffering from T. saginata and 7 of the 10 harbouring H. nana.
[ABSTRACT]   Full text not available  [PDF]
  1,870 149 -
CONFERENCE ABSTRACTS
Proceedings of the Indian Pharmacological Society XII Annual Conference, December 29-31, 1979, Abstracts
IPS
January-March 1980, 12(1):31-65
. One gram of sodium tolbutamide was administered orally to twenty-five patients with hepatic cirrhosis and five normal subjects and its serial plasma levels were measured both before and after phenobarbital pretreatment. Phenobarbital administration reduced the enhanced half life (t1/2) of tolbutamide in nonsmokers with hepatic cirrhosis but no significant alteration was produced in smokers with hepatic cirrhosis.
[ABSTRACT]   Full text not available  [PDF]
  1,282 307 -
RESEARCH PAPER
Effect of phenobarbitone pretreatment on tolbutamide half life in cases of hepatic cirrhosis
D Singh, R Vijayavargiya, P Mehta, AL Kakrani
January-March 1980, 12(1):27-30
. One gram of sodium tolbutamide was administered orally to twenty-five patients with hepatic cirrhosis and five normal subjects and its serial plasma levels were measured both before and after phenobarbital pretreatment. Phenobarbital administration reduced the enhanced half life (t1/2) of tolbutamide in nonsmokers with hepatic cirrhosis but no significant alteration was produced in smokers with hepatic cirrhosis.
[ABSTRACT]   Full text not available  [PDF]
  1,260 84 -
On the mechanism of action of initial hypotensive response to acute intravenous administration of guanethidine in anaesthetized dog
PS Zade, MK Jagtap
January-March 1980, 12(1):23-26
. Guanethidine when administered as bolus intravenous injection produces sharp and short lived initial fall in blood pressure (phase I), followed by a rise in blood pressure (phase II). These initial changes are followed by a progressive fall in blood pressure (phase III) lasting for several days. In the present study an attempt is made to analyse the mechanism of action of the initial fall in BP (phase I). Our observations indicate that this initial fall in BP seen after intravenous guanethidne administration is partly due to activation of peripheral beta adrenergic receptors and partly due to direct peripheral vasodilatation.
[ABSTRACT]   Full text not available  [PDF]
  1,030 79 -
ORATION
Trail of search of an apprentice teacher
BB Roy
January-March 1980, 12(1):1-18
Full text not available  [PDF]
  815 84 -
Site Map | Home | Contact Us | Feedback | Copyright and Disclaimer
Online since 20th July '04
Published by Wolters Kluwer - Medknow